Notice: This company has been marked as potentially delisted and may not be actively trading. Chembio Diagnostics (CEMI) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ANY LAB TEST NOW Forms Strategic Partnership with ChembioApril 17, 2024 | finance.yahoo.comQuest Diagnostics Inc DGXNovember 2, 2023 | morningstar.comQualigen Therapeutics Sells FastPack Diagnostics Business to ChembioJuly 24, 2023 | marketwatch.comBiosynex Completes Acquisition of Chembio Diagnostics, Inc.April 27, 2023 | finance.yahoo.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Laboratory (LH), Arbutus Biopharma (ABUS) and Chembio Diagnostics (CEMI)April 27, 2023 | markets.businessinsider.comShareholder Alert: Ademi LLP investigates whether Chembio Diagnostics, Inc. has obtained a Fair Price in its transaction with BiosynexApril 20, 2023 | benzinga.comChembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023April 19, 2023 | finance.yahoo.comChembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively BuyingApril 14, 2023 | msn.comChembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023April 10, 2023 | finance.yahoo.comChembio’s CEO Letter to StockholdersApril 3, 2023 | finance.yahoo.comChembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023March 21, 2023 | finance.yahoo.comBiosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.March 15, 2023 | finance.yahoo.comChembio Announces Letter to Stockholders Regarding Tender OfferMarch 15, 2023 | finance.yahoo.comChembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis SystemFebruary 24, 2023 | finance.yahoo.comMoore Kuehn Encourages ALBO, LPTX, ALR, and CEMI Investors to Contact Law FirmFebruary 8, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Chembio Diagnostics, Inc. BuyoutFebruary 2, 2023 | wsj.comFrench Rapid Testing Company Scoops Up Chembio Diagnostics For $17MFebruary 1, 2023 | finance.yahoo.comBiosynex and Chembio Diagnostics Announce Definitive Acquisition AgreementJanuary 31, 2023 | finance.yahoo.comTrading was temporarily halted for "CEMI" at 04:01 PM with a stated reason of "News pending."January 31, 2023 | marketbeat.comCEMI Chembio Diagnostics, Inc.January 21, 2023 | seekingalpha.comChembio DiagnosticsJanuary 7, 2023 | forbes.comChembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis SystemNovember 28, 2022 | finance.yahoo.comChembio Diagnostics, Inc. (CEMI) Q3 2022 Earnings Call TranscriptNovember 6, 2022 | seekingalpha.comChembio Diagnostics Reports Third Quarter 2022 Financial ResultsNovember 3, 2022 | finance.yahoo.comChembio Diagnostics to Report Third Quarter 2022 Financial Results on November 3, 2022October 20, 2022 | finance.yahoo.comChembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm AssaySeptember 6, 2022 | finance.yahoo.comIs Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has SlowedSeptember 3, 2022 | finance.yahoo.comRapid Test For Monkeypox? NY-Based Chembio Diagnostics Thinks They Can Pull It OffAugust 16, 2022 | finance.yahoo.comChembio Diagnostics Evaluates Monkeypox Rapid Point-of-Care Test DevelopmentAugust 16, 2022 | finance.yahoo.comChembio Diagnostics Reports Second Quarter 2022 Financial ResultsAugust 4, 2022 | finance.yahoo.comChembio Diagnostics to Report Second Quarter 2022 Financial Results on August 4, 2022July 21, 2022 | finance.yahoo.comChembio Expands DistributionJune 15, 2022 | baystreet.caChembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial ChannelJune 15, 2022 | finance.yahoo.comChembio's inks contract for HIV test to be made by Reszon Diagnostics at Malaysia facilityMay 17, 2022 | seekingalpha.comChembio Diagnostics Announces Agreement for Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK Assay at Chembio Diagnostics Malaysia FacilityMay 17, 2022 | finance.yahoo.comChembio Diagnostics, Inc. (CEMI) CEO Rick Eberly on Q1 2022 Results - Earnings Call TranscriptMay 8, 2022 | seekingalpha.comChembio Diagnostics Reports First Quarter 2022 Financial ResultsMay 5, 2022 | finance.yahoo.comChembio Diagnostics Q1 2022 Earnings PreviewMay 4, 2022 | seekingalpha.comChembio Diagnostics to Report First Quarter 2022 Financial Results on May 5, 2022April 21, 2022 | finance.yahoo.comWhy Chembio Diagnostics Shares Are FallingMarch 4, 2022 | benzinga.comChembio Diagnostics Reports Fourth Quarter and Full Year 2021 Financial ResultsMarch 3, 2022 | finance.yahoo.comChembio Diagnostics Q4 2021 Earnings PreviewMarch 3, 2022 | seekingalpha.comChembio Diagnostics to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022February 17, 2022 | finance.yahoo.comChembio Diagnostics, Inc. Common Stock (CEMI)January 21, 2022 | nasdaq.comChembio Diagnostics appoints CFOJanuary 5, 2022 | seekingalpha.comChembio Diagnostics Announces Appointment of Larry Steenvoorden as Chief Financial OfficerJanuary 5, 2022 | finance.yahoo.comChembio Diagnostics Inc. Shares Close the Day 30.1% Lower - Daily WrapDecember 30, 2021 | nasdaq.comChembio Diagnostics Slides After FDA Declines to Review EUADecember 29, 2021 | finance.yahoo.comPre-market Movers: PIXY, NEW, CEMI, SYTA, AUVI…December 29, 2021 | markets.businessinsider.comChembio Diagnostics Receives SAHPRA Approval for DPP SARS-CoV-2 Antigen TestNovember 29, 2021 | finance.yahoo.com Get Chembio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CEMI and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here CEMI Media Mentions By Week CEMI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CEMI News Sentiment▼0.000.43▲Average Medical News Sentiment CEMI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CEMI Articles This Week▼00▲CEMI Articles Average Week Get Chembio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CEMI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Orgenesis News Today Tonix Pharmaceuticals News Today Citius Pharmaceuticals News Today Syros Pharmaceuticals News Today Eupraxia Pharmaceuticals News Today Immuneering News Today RAPT Therapeutics News Today Mural Oncology News Today Shattuck Labs News Today Reneo Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CEMI) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chembio Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chembio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
